Loading...
NPI 1689975021 · Westborough, MA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Esoterix Genetic Laboratories, LLC is a clinical medical laboratory provider located in Westborough, Massachusetts. This profile covers 1 Medicare and 54 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Esoterix Genetic Laboratories, LLC |
| Address | 3400 Computer Dr |
| City | Westborough |
| State | MA |
| ZIP | 01581 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 16, 2010 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $56.9M |
| Medicare | $37.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 70 | $550 | $37.6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81220 | 1 | 10 | 20 | $550 | $18.5K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
54 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 130,500 | $250 | $32M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 117,620 | $70 | $7.8M |
| 81329 | The lab analyst performs the technical lab test to detect deletions in the survival of motor neuron 1 (SMN1), telomeric, gene and may also analyze the survival of motor neuron 2 (SMN2), centromeric,… | 138,880 | $50 | $6.7M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 10,070 | $210 | $2.1M |
| 81243 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for fragile X messenger ribonucleoprotein 1, also known as FMR1, typically to detect common abnormal… | 78,410 | $20 | $1.7M |
| 81257 | The lab analyst performs the technical lab test to detect the presence of specific changes and possible deleted nucleotides in the alpha globin 1 and alpha globin 2 genes, also known as HBA1/HBA2,… | 21,340 | $30 | $725.6K |
| 81361 | The lab analyst performs the technical lab test to detect the presence of specific changes in the hemoglobin, subunit beta (HBB) gene specifically for common variants, such as HbS, HbC, HbE. | 22,530 | $30 | $721.1K |
| 81401 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 2 molecular pathology code. | 8,920 | $80 | $704.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 32,110 | $20 | $513.8K |
| 81200 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for aspartoacylase, also known as ASPA. | 22,890 | $20 | $412.1K |
Showing 1–10 of 54
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
54 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 1 | 20 | 310 | $260 | $2.1M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 1 | 10 | 1,720 | $430 | $1.2M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 3 | 130 | 1,830 | $60 | $974.3K |
| 81329 | The lab analyst performs the technical lab test to detect deletions in the survival of motor neuron 1 (SMN1), telomeric, gene and may also analyze the survival of motor neuron 2 (SMN2), centromeric,… | 1 | 10 | 1,210 | $50 | $714K |
| 81361 | The lab analyst performs the technical lab test to detect the presence of specific changes in the hemoglobin, subunit beta (HBB) gene specifically for common variants, such as HbS, HbC, HbE. | 1 | 10 | 11,280 | $30 | $365.1K |
| 81443 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen for genetic sequences of at least 15 genes, such as the 20 gene examples listed in the code descriptor. The… | 1 | 10 | 2,050 | $150 | $313.2K |
| 81243 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for fragile X messenger ribonucleoprotein 1, also known as FMR1, typically to detect common abnormal… | 1 | 10 | 380 | $20 | $227.4K |
| 81257 | The lab analyst performs the technical lab test to detect the presence of specific changes and possible deleted nucleotides in the alpha globin 1 and alpha globin 2 genes, also known as HBA1/HBA2,… | 1 | 10 | 40 | $40 | $192.3K |
| 81330 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for sphingomyelin phosphodiesterase 1, acid lysosomal, also known as SMPD1. | 1 | 10 | 11,220 | $20 | $175.6K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 8 | 100 | 1,930 | $20 | $155.5K |
Showing 1–10 of 54
Other providers in the same ZIP code as Esoterix Genetic Laboratories, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Shriver Nursing Services, Inc | MA | Nursing Care Agency | $0 | $62.7M |
| Bsd Home Care Management LLC | MA | Adult Care Home Facility | $0 | $13.2M |
| Bsd Home Care Management LLC | MA | Home Health Agency | $0 | $9.4M |
| Commonwealth Of Massachusetts-dmh | MA | Case Management Agency | $0 | $7.8M |
| Town Of Westborough | MA | Land Ambulance | $412.3K | $1.4M |
| Gregory Malloy | MA | Physical Medicine & Rehabilitation Physician | $149.3K | $403.9K |
| Sotiraq Terova | MA | Internal Medicine Physician | $290.9K | $0 |
| James Karadimos | MA | Podiatrist | $160.3K | $0 |
| Eriola Terova | MA | Internal Medicine Physician | $153.9K | $0 |
| John Vincent Turchetta | MA | Physical Medicine & Rehabilitation Physician | $136.9K | $15.2K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.